MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
469.00
3 (0.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
591.00
501.50
521.70
493.80
474.20
413.10
457.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
591.00
501.50
521.70
493.80
474.20
413.10
457.70
Raw Material Cost
511.30
430.10
442.80
424.60
424.20
358.20
391.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
151.10
125.60
136.30
129.70
126.50
102.70
121.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.30
7.60
6.90
4.60
4.80
4.30
5.80
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
-16.54
-13.32
-14.32
-13.43
-13.13
-10.70
-12.76
Total Expenditure (Excl Depreciation)
511.30
430.10
442.80
424.60
424.20
358.20
391.80
Operating Profit (PBDIT) excl Other Income
79.7
71.39999999999999
78.89999999999999
69.2
50
54.900000000000006
65.9
Other Income
19.30
4.60
2.50
4.70
8.40
14.60
12.40
Operating Profit (PBDIT)
150.40
111.40
115.50
106.30
88.30
99.10
105.90
Interest
14.30
7.60
6.90
4.60
4.80
4.30
5.80
Exceptional Items
0.00
0.00
-4.00
-3.80
-0.80
0.00
0.00
Gross Profit (PBDT)
79.70
71.40
78.90
69.20
50.00
54.90
65.90
Depreciation
51.40
35.40
34.10
32.40
29.90
29.60
27.60
Profit Before Tax
84.70
68.50
70.40
65.40
52.80
64.90
72.40
Tax
19.60
17.30
16.70
14.70
10.10
11.60
15.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
64.60
51.20
53.60
50.50
41.50
52.90
56.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
64.60
51.20
53.60
50.50
41.50
52.90
56.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.50
0.10
0.10
0.20
1.20
0.40
0.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
65.10
51.30
53.70
50.70
42.70
53.30
57.10
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.4
0.4
0.4
0.4
0.4
0.4
0.4
Reserves
1,452.10
1,399.60
1,356.40
1,306.30
1,282.00
1,193.10
1,147.50
Earnings per share (EPS)
4.31
3.41
3.57
3.37
2.8
3.54
3.8
Diluted Earnings per share
4.31
3.41
3.57
3.37
2.8
3.54
3.8
Operating Profit Margin (Excl OI)
13.49%
14.24%
15.12%
14.01%
10.54%
13.29%
14.4%
Gross Profit Margin
23.03%
20.72%
20.03%
19.81%
17.44%
22.88%
21.85%
PAT Margin
10.93%
10.21%
10.27%
10.23%
8.75%
12.81%
12.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 24.63% vs 3.85% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 52.46% vs -31.68% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 64.08% vs -21.36% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 197.92% vs 17.07% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of MedCap AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
591.00
268.85
322.15
119.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
591.00
268.85
322.15
119.83%
Raw Material Cost
511.30
113.85
397.45
349.10%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
151.10
0.00
151.10
Power Cost
0
0
0.00
Manufacturing Expenses
14.30
0.00
14.30
Selling and Distribution Expenses
0.00
56.45
-56.45
-100.00%
Other Expenses
-16.54
5.16
-21.70
-420.54%
Total Expenditure (Excl Depreciation)
511.30
221.85
289.45
130.47%
Operating Profit (PBDIT) excl Other Income
79.70
47.00
32.70
69.57%
Other Income
19.30
-4.51
23.81
527.94%
Operating Profit (PBDIT)
150.40
66.44
83.96
126.37%
Interest
14.30
0.00
14.30
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
79.70
155.00
-75.30
-48.58%
Depreciation
51.40
23.95
27.45
114.61%
Profit Before Tax
84.70
42.49
42.21
99.34%
Tax
19.60
9.24
10.36
112.12%
Provisions and contingencies
0
0
0.00
Profit After Tax
64.60
33.26
31.34
94.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
64.60
33.26
31.34
94.23%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.50
0.00
0.50
Other related items
0.00
0.00
0.00
Consolidated Net Profit
65.10
33.26
31.84
95.73%
Equity Capital
0
0
0.00
Face Value
0.40
0.00
0.00
Reserves
1,452.10
4,273.05
-2,820.95
-66.02%
Earnings per share (EPS)
4.31
0.65
3.66
563.08%
Diluted Earnings per share
4.31
0.65
3.66
563.08%
Operating Profit Margin (Excl OI)
13.49%
17.48%
0.00
-3.99%
Gross Profit Margin
23.03%
24.71%
0.00
-1.68%
PAT Margin
10.93%
12.37%
0.00
-1.44%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 59.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 17.85% vs -3.87% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 24.63% vs 3.85% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.51 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 26.90% vs -4.47% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 52.46% vs -31.68% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.11 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 22.75% vs -5.49% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 64.08% vs -21.36% in Dec 2024

Quarterly - Interest
Interest 1.43 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 88.16% vs 10.14% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 197.92% vs 17.07% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.49%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024